BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9479345)

  • 41. Rapid rescreening of cervical smears for internal quality control.
    Diehl AR; Prolla JC
    Acta Cytol; 1998; 42(4):949-53. PubMed ID: 9684583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
    Cernescu EC; Anton G; Ruţă S; Cernescu C
    Roum Arch Microbiol Immunol; 2013; 72(2):93-104. PubMed ID: 24187808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
    van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD
    Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of computer-assisted rescreening as an ancillary tool to subclassify AGUS cervical smears.
    Chhieng DC; Elgert PA; Xiong Y; Cangiarella JF; Cohen JM
    Diagn Cytopathol; 2000 Sep; 23(3):165-70. PubMed ID: 10945903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The AutoCyte preparation system for gynecologic cytology.
    Howell LP; Davis RL; Belk TI; Agdigos R; Lowe J
    Acta Cytol; 1998; 42(1):171-7. PubMed ID: 9479336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid rescreening of cervical smears as a quality control method in a high-risk population.
    Michelow P; McKee G; Hlongwane F
    Cytopathology; 2006 Jun; 17(3):110-5. PubMed ID: 16719852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system.
    Bolick DR; Hellman DJ
    Acta Cytol; 1998; 42(1):209-13. PubMed ID: 9479342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AutoCyte SCREEN interactive automated primary cytology screening system. A preliminary evaluation.
    Takahashi M; Kimura M; Akagi A; Naitoh M
    Acta Cytol; 1998; 42(1):185-8. PubMed ID: 9479338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Technologic advances for evaluation of cervical cytology: is newer better?
    Hartmann KE; Nanda K; Hall S; Myers E
    Obstet Gynecol Surv; 2001 Dec; 56(12):765-74. PubMed ID: 11753179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
    Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
    Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of PAPNET-assisted cervical rescreening.
    Doornewaard H; Woudt JM; Strubbe P; van de Seijp H; van den Tweel JG
    Cytopathology; 1997 Oct; 8(5):313-21. PubMed ID: 9313983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid rescreening of cervical smears: an improved method of quality control.
    Dudding N
    Cytopathology; 1995 Apr; 6(2):95-9. PubMed ID: 7795170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology].
    Cosentino A; Ghidoni D; Salemi M; Folicaldi S; Amadori A; Zani J; Grasso G; Bondi A
    Pathologica; 1999 Apr; 91(2):101-6. PubMed ID: 10484869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
    Keyhani-Rofagha S; Palma T; O'Toole RV
    Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
    Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.